Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
Scope of the Report:
This report focuses on the Embolization Particle in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Market Segment by Countries, covering
United States
United Kingdom
Canada
Germany
France
Italy
Spain
Market Segment by Type, covers
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Market Segment by Applications, can be divided into
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Other
There are 19 Chapters to deeply display the North America and Europe Embolization Particle market.
Chapter 1, to describe Embolization Particle Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Embolization Particle, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Embolization Particle, for each country, from 2013 to 2018;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;
Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;
Chapter 14, Embolization Particle market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers, etc.
Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.
Frequently Asked Questions
These dominant industry players use well planned strategies to occupied highest market share in this market. Some of the top players in [Keyword] business includes.
[Company list]
As per [Keyword] market analysis, North America is forecasted to occupied major share in the [Keyword] market.
The statistical data of the dominant industry player of [Keyword] market can be acquired from the company profile segment described in the report. This segment come up with analysis of major player’s in the [Keyword] market, also their last five-year revenue, segmental, product offerings, key strategies adopted and geographical revenue produced.
The report come up with a segment of the [Keyword] market based on Type, Region, and Application, Also offer a determined view on the [Keyword] market.
The report offers a nitty-gritty estimation of the market by providing data on various viewpoints that incorporate, restraints, drivers, and opportunities threats. This data can help in making suitable decisions for stakeholders before investing.
The sample report for [Keyword] market can be received after the apply from the website.
Table Of Content
Table of Contents
1 Market Overview
1.1 Embolization Particle Introduction
1.2 Market Analysis by Type
1.2.1 Microspheres
1.2.2 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.3 Drug-eluting Beads (DEBs)
1.2.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Market Analysis by Applications
1.3.1 Uterine Fibroid Embolization
1.3.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.3 Liver Tumor Embolization
1.3.4 Trauma Embolization
1.3.5 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sirtex Medical
2.1.1 Business Overview
2.1.2 Embolization Particle Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Sirtex Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merit Medical
2.2.1 Business Overview
2.2.2 Embolization Particle Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merit Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Cook Medical
2.3.1 Business Overview
2.3.2 Embolization Particle Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Cook Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 BTG Medical
2.4.1 Business Overview
2.4.2 Embolization Particle Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 BTG Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boston Scientific Corporation
2.5.1 Business Overview
2.5.2 Embolization Particle Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Boston Scientific Corporation Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Terumo Corporation
2.6.1 Business Overview
2.6.2 Embolization Particle Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Terumo Corporation Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 HENGRUI Medical
2.7.1 Business Overview
2.7.2 Embolization Particle Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 HENGRUI Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 INterface BIOmaterials B.V.
2.8.1 Business Overview
2.8.2 Embolization Particle Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Alicon
2.9.1 Business Overview
2.9.2 Embolization Particle Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Alicon Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America and Europe Embolization Particle Market Competition, by Manufacturer
3.1 North America and Europe Embolization Particle Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Embolization Particle Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Embolization Particle Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Embolization Particle Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Embolization Particle Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Embolization Particle Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Embolization Particle Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America and Europe Embolization Particle Market Analysis by Countries/Regions
4.1 North America and Europe Embolization Particle Sales Market Share by Countries/Regions
4.2 North America and Europe Embolization Particle Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Embolization Particle Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Embolization Particle Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Embolization Particle Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Embolization Particle Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Embolization Particle Revenue Market Share by Countries (2013-2018)
5 North America and Europe Market Segmentation Embolization Particle by Type
5.1 North America and Europe Embolization Particle Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Embolization Particle Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Embolization Particle Revenue and Market Share by Type (2013-2018)
5.2 Microspheres Sales Growth and Price
5.2.1 North America and Europe Microspheres Sales Growth (2013-2018)
5.2.2 North America and Europe Microspheres Price (2013-2018)
5.3 Particles (e.g. PVA Particles, Gelfoam Particles) Sales Growth and Price
5.3.1 North America and Europe Particles (e.g. PVA Particles, Gelfoam Particles) Sales Growth (2013-2018)
5.3.2 North America and Europe Particles (e.g. PVA Particles, Gelfoam Particles) Price (2013-2018)
5.4 Drug-eluting Beads (DEBs) Sales Growth and Price
5.4.1 North America and Europe Drug-eluting Beads (DEBs) Sales Growth (2013-2018)
5.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Sales Growth and Price
5.5.1 North America and Europe Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Sales Growth (2013-2018)
5.5.2 North America and Europe Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Price (2013-2018)
6 North America and Europe Market Segmentation Embolization Particle by Application
6.1 North America and Europe Embolization Particle Sales Market Share by Application (2013-2018)
6.2 Uterine Fibroid Embolization Sales Growth (2013-2018)
6.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Sales Growth (2013-2018)
6.4 Liver Tumor Embolization Sales Growth (2013-2018)
6.5 Trauma Embolization Sales Growth (2013-2018)
6.6 Other Sales Growth (2013-2018)
7 United States Embolization Particle Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Embolization Particle Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Embolization Particle Sales and Market Share by Type (2013-2018)
7.2.1 United States Embolization Particle Sales by Type (2013-2018)
7.2.2 United States Embolization Particle Sales Market Share by Type (2013-2018)
7.3 United States Embolization Particle Sales and Market Share by Application (2013-2018)
7.3.1 United States Embolization Particle Sales by Application (2013-2018)
7.3.2 United States Embolization Particle Sales Market Share by Application (2013-2018)
7.4 United States Embolization Particle Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Embolization Particle Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Embolization Particle Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Embolization Particle Export and Import (2013-2018)
8 United Kingdom Embolization Particle Sales, Revenue, by Type, Application and Manufacturers
8.1 United Kingdom Embolization Particle Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Embolization Particle Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Embolization Particle Sales by Type (2013-2018)
8.2.2 United Kingdom Embolization Particle Sales Market Share by Type (2013-2018)
8.3 United Kingdom Embolization Particle Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Embolization Particle Sales by Application (2013-2018)
8.3.2 United Kingdom Embolization Particle Sales Market Share by Application (2013-2018)
8.4 United Kingdom Embolization Particle Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Embolization Particle Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Embolization Particle Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Embolization Particle Export and Import (2013-2018)
9 Canada Embolization Particle Sales, Revenue, by Type, Application and Manufacturers
9.1 Canada Embolization Particle Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Embolization Particle Sales and Market Share by Type (2013-2018)
9.2.1 Canada Embolization Particle Sales by Type (2013-2018)
9.2.2 Canada Embolization Particle Sales Market Share by Type (2013-2018)
9.3 Canada "&Sheet1!$B$1&" Sales and Market Share by Application (2013-2018)"
9.3.1 Canada Embolization Particle Sales by Application (2013-2018)
9.3.2 Canada Embolization Particle Sales Market Share by Application (2013-2018)
9.4 Canada Embolization Particle Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Embolization Particle Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Embolization Particle Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Embolization Particle Export and Import (2013-2018)
10 Germany Embolization Particle Sales, Revenue, by Type, Application and Manufacturers
10.1 Germany Embolization Particle Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Embolization Particle Sales and Market Share by Type (2013-2018)
10.2.1 Germany Embolization Particle Sales by Type (2013-2018)
10.2.2 Germany Embolization Particle Sales Market Share by Type (2013-2018)
10.3 Germany Embolization Particle Sales and Market Share by Application (2013-2018)
10.3.1 Germany Embolization Particle Sales by Application (2013-2018)
10.3.2 Germany Embolization Particle Sales Market Share by Application (2013-2018)
10.4 Germany Embolization Particle Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Embolization Particle Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Embolization Particle Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Embolization Particle Export and Import (2013-2018)
11 France Embolization Particle Sales, Revenue, by Type, Application and Manufacturers
11.1 France Embolization Particle Revenue, Sales and Growth Rate (2013-2018)
11.2 France Embolization Particle Sales and Market Share by Type (2013-2018)
11.2.1 France Embolization Particle Sales by Type (2013-2018)
11.2.2 France Embolization Particle Sales Market Share by Type (2013-2018)
11.3 France "&Sheet1!$B$1&" Sales by Application (2013-2018)"
11.3.1 France Embolization Particle Sales by Application (2013-2018)
11.3.2 France Embolization Particle Sales Market Share by Application (2013-2018)
11.4 France Embolization Particle Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Embolization Particle Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Embolization Particle Revenue and Market Share by Manufacturer
11.5 France Embolization Particle Export and Import (2013-2018)
12 Italy Embolization Particle Sales, Revenue, by Type, Application and Manufacturers
12.1 Italy Embolization Particle Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Embolization Particle Sales and Market Share by Type (2013-2018)
12.2.1 Italy Embolization Particle Sales by Type (2013-2018)
12.2.2 Italy Embolization Particle Sales Market Share by Type (2013-2018)
12.3 Italy Embolization Particle Sales and Market Share by Application (2013-2018)
12.3.1 Italy Embolization Particle Sales by Application (2013-2018)
12.3.2 Italy Embolization Particle Sales Market Share by Application (2013-2018)
12.4 Italy Embolization Particle Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Embolization Particle Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Embolization Particle Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Embolization Particle Export and Import (2013-2018)
13 Spain Embolization Particle Sales, Revenue, by Type, Application and Manufacturers
13.1 Spain Embolization Particle Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Embolization Particle Sales and Market Share by Type (2013-2018)
13.2.1 Spain Embolization Particle Sales by Type (2013-2018)
13.2.2 Spain Embolization Particle Sales Market Share by Type (2013-2018)
13.3 Spain Embolization Particle Sales by Application (2013-2018)
13.3.1 Spain Embolization Particle Sales by Application (2013-2018)
13.3.2 Spain Embolization Particle Sales Market Share by Application (2013-2018)
13.4 Spain Embolization Particle Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Embolization Particle Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Embolization Particle Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Embolization Particle Export and Import (2013-2018)
14 Embolization Particle Market Forecast (2018-2023)
14.1 North America and Europe Embolization Particle Sales, Revenue and Growth Rate (2018-2023)
14.2 Embolization Particle Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Embolization Particle Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Embolization Particle Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Embolization Particle Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Embolization Particle Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Embolization Particle Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Embolization Particle Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Embolization Particle Sales and Growth Rate Forecast (2018-2023)
14.3 Embolization Particle Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Embolization Particle Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Embolization Particle Market Share Forecast by Type (2018-2023)
14.4 Embolization Particle Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Embolization Particle Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Embolization Particle Market Share Forecast by Application (2018-2023)
15 Embolization Particle Manufacturing Cost Analysis
15.1 Embolization Particle Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Embolization Particle
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Embolization Particle Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Embolization Particle Major Manufacturers in 2017
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Data Source
Inquiry For Buying
North America and Europe Embolization Particle
Please fill out the form. We will contact you within 24 hours:
All fields required...
Request Sample
North America and Europe Embolization Particle
Please fill out the form. We will contact you within 24 hours:
All fields required...
